Circulating Angiogenic Factors and Risk of Adverse Maternal and Perinatal Outcomes in Twin Pregnancies With Suspected Preeclampsia

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

2003 • 3,707 citations

Circulating angiogenic factors and the risk of preeclampsia*

2004 • 2,591 citations

ACOG PRACTICE BULLETIN

2009 • 1,049 citations

Practice bulletin #33: diagnosis and management of preeclampsia and eclampsia

2002 • 1,018 citations

Regulation of Human Placental Development by Oxygen Tension

1997 • 905 citations

Maternal Mortality From Preeclampsia/Eclampsia

2012 • 783 citations

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

2012 • 578 citations

Hypertensive disorders in twin versus singleton gestations

2000 • 504 citations

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

2010 • 492 citations

An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia

2009 • 396 citations

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

2005 • 337 citations

Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries

2006 • 322 citations

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

2009 • 261 citations

Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?

2008 • 217 citations

Hypoxia and sFlt-1 in Preeclampsia: The “Chicken-and-Egg” Question

2004 • 193 citations

Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies

2005 • 134 citations

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

2011 • 130 citations

Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study

2009 • 127 citations

Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy

2006 • 108 citations

Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia

2010 • 103 citations

Hypertensive disorders in twin pregnancy

1995 • 86 citations

Vitamin C and E Supplementation to Prevent Spontaneous Preterm Birth

2010 • 61 citations

Doppler assessment of the uterine circulation in the second trimester in twin pregnancies: prediction of pre‐eclampsia, fetal growth restriction and birth weight discordance

2002 • 57 citations

Circulating angiogenic factors in singleton vs multiple-gestation pregnancies

2008 • 51 citations

Prediction of Adverse Maternal Outcomes in Preeclampsia

2012 • 39 citations

Twin Pregnancy and the Risk of Preeclampsia: Bigger Placenta or Relative Ischemia?

2009 • 36 citations

Reference ranges for Doppler assessment of uterine artery resistance and pulsatility indices in dichorionic twin pregnancies

2010 • 30 citations

Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies

2011 • 27 citations

Maternal angiogenic profile in pregnancies that remain normotensive

2011 • 24 citations

Technical performance of the first fully automated assays for human soluble fms-like tyrosine kinase 1 and human placental growth factor

2009 • 15 citations

Deleted Work

1955 • 0 citations